The FDA considers it a non-toxic substance under the Generally Recognized as Safe (GRAS) classification for specific applications
What makes our program different We start with a whole-person assessment (medical, psychiatric, metabolic, and lifestyle) and co-create a plan you can live with
This once-weekly injection has shown an average weight loss of 15% over 68 weeks in clinical trials, making it a profound option for adults battling obesity or those with associated health conditions
Delayed Gastric Emptying: Prolongs satiety, enhancing nutrient absorption
The thresholds where high or low blood sugar crosses into emergency territory are more specific than most people realize, and the two conditions require very different responses
the second shows the goals communities discuss for each and, crucially, the honest evidence status behind those discussions